Global Injection Pen Market Dominated by Novo Nordisk (Denmark), Eli Lilly (US), and Sanofi (France)
Rising prevalence of chronic diseases, favorable reimbursement scenario and government support, and the increasing number of regulatory approvals resulting in the increased adoption among patients.
The global injection pen market is expected to reach $41.38 Billion by 2022 from $30.97 Billion in 2017, at a CAGR of 6.0%.
Segments
The market is segmented on the basis...
Emerging Trends in Injection Pen Market by Types, Revenue, Industry Growth and Forecast 2022
Rising prevalence of chronic diseases, favorable reimbursement scenario and government support, and the increasing number of regulatory approvals resulting in the increased adoption amongst patients.
The global injection pen market is expected to reach USD 41.38 Billion by 2022 from USD 30.97 Billion in 2017, at a CAGR of 6.0%.
Market Dynamics
+ Drivers
+ Growing Prevalence...